A favorite trade of 2020 and 2021—buying into a startup shortly before the company is expected to go public, often through ...

CROWN POINT, Ind. — OYE Therapeutics Inc., a privately held biopharmaceutical company developing first-in-class intravenous caffeine-based therapies for anesthesia recovery and opioid-induced ...

For early-stage founders and investors attempting to structure investment in an early stage (pre-seed) company, the choice between a Simple Agreement for Future Equity (SAFE) and a Convertible Note ...

Jim Mellon, Non-Executive Chair of Agronomics, commented:- ...

The biotech firm Alamar Biosciences has successfully closed an oversubscribed convertible notes round while strengthening its ...

MINNEAPOLIS, July 28, 2025 (GLOBE NEWSWIRE) -- Celcuity Inc. (Nasdaq: CELC) (the “Company”), a clinical-stage biotechnology company pursuing development of targeted therapies for oncology, today ...

MIDLAND, Texas--(BUSINESS WIRE)--AST SpaceMobile, Inc. (“AST SpaceMobile”) (NASDAQ: ASTS), the company building the first and only space-based cellular broadband network accessible directly by ...

NEW YORK, Dec. 01, 2025 (GLOBE NEWSWIRE) -- IREN Limited (NASDAQ: IREN) (“IREN”) today announced its intention to offer, subject to market and other conditions, $1 billion aggregate principal amount ...

AUSTIN, Texas and NEW YORK, Dec. 11, 2025 (GLOBE NEWSWIRE) -- T1 Energy Inc. (NYSE: TE) ( “T1,” “T1 Energy” or the “Company”) today announced the pricing of its previously announced underwritten ...

$1.15 billion 0.00% Convertible Senior Notes offering (27.50% conversion premium) The repurchase of approximately $460 million of the common stock from investors in the Convertible Notes CleanSpark ...